These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9826117)

  • 1. Lessons from glucosylceramide and Gaucher's disease.
    Luft FC
    J Mol Med (Berl); 1998 Oct; 76(11):723-4. PubMed ID: 9826117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenic mechanism and therapies for Gaucher's disease].
    Liu LY; Du SC; Zhang J; Ma D
    Yi Chuan; 2015 Jun; 37(6):510-6. PubMed ID: 26351046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
    Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM; Kobayashi T; Suzuki K
    Clin Chim Acta; 1982 Jan; 118(1):1-7. PubMed ID: 7053901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of p38 Mitogen-Activated Protein Kinase in Gaucher's Disease.
    Kitatani K; Wada M; Perry D; Usui T; Sun Y; Obeid LM; Yaegashi N; Grabowski GA; Hannun YA
    PLoS One; 2015; 10(8):e0136633. PubMed ID: 26312487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell lymphoma and myeloma in murine Gaucher's disease.
    Pavlova EV; Wang SZ; Archer J; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2013 Sep; 231(1):88-97. PubMed ID: 23775597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the pathogenesis of Gaucher's disease: tissue distribution and biliary excretion of [14C]L-glucosylceramide in rats.
    Tokoro T; Gal AE; Gallo LL; Brady RO
    J Lipid Res; 1987 Aug; 28(8):968-72. PubMed ID: 3668390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minos-insertion mutant of the Drosophila GBA gene homologue showed abnormal phenotypes of climbing ability, sleep and life span with accumulation of hydroxy-glucocerebroside.
    Kawasaki H; Suzuki T; Ito K; Takahara T; Goto-Inoue N; Setou M; Sakata K; Ishida N
    Gene; 2017 May; 614():49-55. PubMed ID: 28286087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher's disease. Enzyme therapy is not enough.
    Grabowski GA
    Lancet; 2001 Dec; 358 Suppl():S29. PubMed ID: 11784578
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards therapy of Gaucher's disease by gene transfer into hematopoietic cells.
    Correll PH; Karlsson S
    Eur J Haematol; 1994 Nov; 53(5):253-64. PubMed ID: 7529197
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular basis of treatment in Gaucher's disease].
    Pocoví M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():32-8. PubMed ID: 22230123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model.
    Marshall J; McEachern KA; Kyros JA; Nietupski JB; Budzinski T; Ziegler RJ; Yew NS; Sullivan J; Scaria A; van Rooijen N; Barranger JA; Cheng SH
    Mol Ther; 2002 Aug; 6(2):179-89. PubMed ID: 12161184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher's disease: a brand leader.
    Cox TM
    Lancet; 1993 Sep; 342(8873):694-5. PubMed ID: 8103817
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM; Weis AL; Shapiro D; Brady RO
    Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.
    Sasagasako N; Kobayashi T; Yamaguchi Y; Shinnoh N; Goto I
    J Biochem; 1994 Jan; 115(1):113-9. PubMed ID: 8188616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-glucosylceramide: synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro.
    Gal AE; Pentchev PG; Massey JM; Brady RO
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3083-6. PubMed ID: 290986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of liver glucosylceramide levels in the "Gaucher" mouse by phosphatidylserine injection.
    Datta SC; Radin NS
    Biochem Biophys Res Commun; 1988 Apr; 152(1):155-60. PubMed ID: 3358758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
    Mizukami H; Mi Y; Wada R; Kono M; Yamashita T; Liu Y; Werth N; Sandhoff R; Sandhoff K; Proia RL
    J Clin Invest; 2002 May; 109(9):1215-21. PubMed ID: 11994410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.